Overexpression of MDR1 using a retroviral vector differentially regulates genes involved in detoxification and apoptosis and confers radioprotection

Radiation Research

Volumn 166, Issue 3, 2006, Pages 463-473

  Maier, Patrick ^a   Fleckenstein, Katharina ^a   Li, Li ^b   Laufs, Stephanie ^c   Zeller, W Jens ^c   Baum, Christopher ^d   Fruehauf, Stefan ^a   Herskind, Carsten ^a   Wenz, Frederik ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; RETROVIRUS VECTOR;

AKT3 GENE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER THERAPY; CONTROLLED STUDY; DETOXIFICATION; EXOCYTOSIS; GENE; GENE CONTROL; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MDR1 GENE; PRIORITY JOURNAL; RADIATION PROTECTION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; LYMPHOCYTES; P-GLYCOPROTEIN; RADIATION DOSAGE; RADIATION PROTECTION; RETROVIRIDAE; TRANSFECTION;

EID: 33748471486     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR0550.1     Document Type: Article

References (57)

1. K. Camphausen and P. J. Tofilon, Combining radiation and molecular targeting in cancer therapy. Cancer Biol. Ther. 3, 247-250 (2004).
2. S. Fruehauf, D. A. Breems, S. Knaan-Shanzer, K. B. Brouwer, R. Haas, B. Lowenberg, K. Nooter, R. E. Ploemacher, D. Valerio and J. J. Boesen, Frequency analysis of multidrug resistance-1 gene transfer into human primitive hematopoietic progenitor cells using the cobblestone area-forming cell assay and detection of vector-mediated P-glycoprotein expression by rhodamine-123. Hum. Gene Ther. 1, 1219-1231 (1996).
3. D. S. Gridley and J. M. Slater, Combining gene therapy and radiation against cancer. Curr. Gene Ther. 4, 231-248 (2004).
4. A. Buschini, E. Anceschi, C. Carlo-Stella, E. Regazzi, V. Rizzoli, P. Poli and C. Rossi, Amifostine (WR-2721) selective protection against melphalan genotoxicity. Leukemia 14, 1642-1651 (2000).
5. J. P. Okunieff, M. Li, W. Liu, J. Sun, B. Fenton, L. Zhang and I. Ding, Keratinocyte growth factors radioprotect bowel and bone marrow but not KHT sarcoma. Am. J. Clin. Oncol. 24, 491-495 (2001).
6. W. Dorr, S. Reichel and K. Spekl, Effects of keratinocyte growth factor (palifermin) administration protocols on oral mucositis (mouse) induced by fractionated irradiation. Radiother. Oncol. 75, 99-105 (2005).
7. M. A. Siddiqui and K. Wellington, Palifermin: In myelotoxic therapy-induced oral mucositis. Drugs 65, 2139-2147 (2005).
8. J. S. Greenberger, M. W. Epperly, J. Gretton, M. Jefferson, S. Nie, M. Bernarding, V. Kagan and H. L. Guo, Radioprotective gene therapy. Curr. Gene. Ther. 3, 183-195 (2003).
9. M. M. Gottesman and I. Pastan, Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62, 385-427 (1993).
10. P. M. Chaudhary and I. B. Roninson, Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66, 85-94 (1991).
11. C. Hesdorffer, J. Ayello, M. Ward, A. Kaubisch, L. Vahdat, C. Balmaceda, T. Garrett, M. Fetell, R. Reiss and K. Antman, Phase I trial of retro viral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. J. Clin. Oncol. 16, 165-172 (1998).
12. P. S. Becker, Y. P. Yu, A. M. Ceredona, W. V. Walsh, J. L. O'Donnell, C. Baum, L. Kallander, P. A. Lowry, T. J. Fitzgerald and F. M. Stewart, Transfer of the multidrug resistance gene, MDR-1, to hematopoietic progenitors from a patient with transformed large cell lymphoma, and demonstration of in vivo chemotherapy protection with dose escalating chemotherapy. Blood 104, 5278 (2004). [abstract]
13. K. H. Cowan, J. A. Moscow, H. Huang, J. A. Zujewski, J. O'Shaughnessy, B. Sorrentino, K. Hines, C. Carter, E. Schneider and A. Nienhuis, Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retro virus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients. Clin. Cancer Res. 5, 1619-1628 (1999).
14. K. M. Tainton, M. J. Smyth, J. T. Jackson, J. E. Tanner, L. Cerruti, S. M. Jane, P. K. Darcy and R. W. Johnstone, Mutational analysis of P-glycoprotein: Suppression of caspase activation in the absence of ATP-dependent drug efflux. Cell Death Differ. 11, 1028-1037 (2004).
15. N. Dainiak, Hematologic consequences of exposure to ionizing radiation. Exp. Hematol. 30, 513-528 (2002).
16. D. W. van Bekkum, Radiation sensitivity of the hemopoietic stem cell. Radiat. Res. 128 (Suppl.), S4-S8 (1991).
17. F. Paris, Z. Fuks, A. Kang, P. Capodieci, G. Juan, D. Ehleiter, A. Haimovitz-Friedman, C. Cordon-Cardo and R. Kolesnick, Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293, 293-297 (2001).
18. T. R. Skopek, H. L. Liber, B. W. Penman and W. G. Thilly, Isolation of a human lymphoblastoid line heterozygous at the thymidine kinase locus: Possibility for a rapid human cell mutation assay. Biochem. Biophys. Res. Commun. 84, 411-416 (1978).
19. R. Knipper, K. Kuehlcke, B. Schiedlmeier, M. Hildinger, C. Lindemann, A. J. Schilz, A. A. Fauser, S. Fruehauf, W. J. Zeller and C. Baum, Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells. Gene Ther. 8, 239-246 (2001).
20. A. J. Schilz, B. Schiedlmeier, K. Kuhlcke, S. Fruehauf, C. Lindemann, W. J. Zeller, M. Grez, A. A. Fauser, C. Baum and H. G. Eckert, MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditions. Mol. Ther. 2, 609-618 (2000).
21. B. Schiedlmeier, K. Kuhlcke, H. G. Eckert, C. Baum, W. J. Zeller and S. Fruehauf, Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice. Blood 95, 1237-1248 (2000).
22. T. M. Chu, B. Weir and R. Wolfinger, A systematic statistical linear modeling approach to oligonucleotide array experiments. Math. Biosci. 176, 35-51 (2002).
23. I. Nicoletti, G. Migliorati, M. C. Pagliacci, F. Grignani and C. Riccardi, A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139, 271-279 (1991).
24. E. E. Furth, W. G. Thilly, B. W. Penman, H. L. Liber and W. M. Rand, Quantitative assay for mutation in diploid human lymphoblasts using microtiter plates. Anal. Biochem. 110, 1-8 (1981).
25. R. Abonour, D. A. Williams, L. Einhorn, K. M. Hall, J. Chen, J. Coffman, C. M. Traycoff, A. Bank, I. Kato and K. Cornetta, Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells. Nat. Med. 6, 652-658 (2000).
26. B. Schiedlmeier, A. J. Schilz, K. Kuhlcke, S. Laufs, C. Baum, W. J. Zeller, H. G. Eckert and S. Fruehauf, Multidrug resistance I gene transfer can confer chemoprotection to human peripheral blood progenitor cells engrafted in immunodeficient mice. Hum. Gene Ther. 13, 233-242 (2002).
27. F. Martinon and J. Tschopp, Inflammatory caspases: Linking an intracellular innate immune system to autoinflammatory diseases. Cell 117, 561-574 (2004).
28. F. Wenz, Y. Yu, H. Nagasawa, A. C. Imrich, P. Keng and J. B. Little, Lack of uncoupling of S phase and mitosis after irradiation in p53-human lymphoblast cell lines. Radiat. Res. 148, 129-134 (1997).
29. F. Wenz, E. I. Azzam and J. B. Little, The response of proliferating cell nuclear antigen to ionizing radiation in human lymphoblastoid cell lines is dependent on p53. Radiat. Res. 149, 32-40 (1998).
30. P. J. Fraker, L. E. King, D. Lill-Elghanian and W. G. Telford, Quantification of apoptotic events in pure and heterogeneous populations of cells using the flow cytometer. Methods Cell Biol. 46, 57-76 (1995).
31. J. B. Little, H. Nagasawa, P. C. Keng, Y. Yu and C. Y. Li, Absence of radiation-induced G1 arrest in two closely related human lymphoblast cell lines that differ in p53 status. J. Biol. Chem. 270, 11033-11036 (1995).
32. H. Herweijer, P. Sonneveld, F. Baas and K. Nooter, Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. J. Natl. Cancer Inst. 82, 1133-1140 (1990).
33. Z. Duan, K. A. Brakora and M. V. Seiden, Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells. Mol. Cancer Ther. 3, 833-838 (2004).
34. A. J. Smith, A. van Helvoort, G. van Meer, K. Szabo, E. Welker, G. Szakacs, A. Varadi, B. Sarkadi and P. Borst, MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping. J. Biol. Chem. 275, 23530-23539 (2000).
35. L. C. Hsu, K. Tani, T. Fujiyoshi, K. Kurachi and A. Yoshida, Cloning of cDNAs for human aldehyde dehydrogenases 1 and 2. Proc. Natl. Acad. Sci. USA 82, 3771-3775 (1985).
36. F. R. Kohn and N. E. Sladek, Ex vivo treatment of murine splenocyte-supplemented bone marrow inocula with mafosfamide prior to allogeneic transplantation in an attempt to prevent lethal graft-versus-host disease without compromising engraftment. Immunopharmacol. Immunotoxicol. 10, 387-398 (1988).
37. A. Ludwig, M. Dietel and H. Lage, Identification of differentially expressed genes in classical and atypical multidrug-resistant gastric carcinoma cells. Anticancer Res. 22, 3213-3221 (2002).
38. J. E. Richmond, R. M. Weimer and E. M. Jorgensen, An open form of syntaxin bypasses the requirement for UNC-13 in vesicle priming. Nature 412, 338-341 (2001).
39. S. J. Scales, B. A. Hesser, E. S. Masuda and R. H. Scheller, Amisyn, a novel syntaxin-binding protein that may regulate SNARE complex assembly. J. Biol. Chem. 277, 28271-28279 (2002).
40. Y. Yu and J. B. Little, p53 is involved in but not required for ionizing radiation-induced caspase-3 activation and apoptosis in human lymphoblast cell lines. Cancer Res. 58, 4277-4281 (1998).
41. A. C. Ruth and I. B. Roninson, Effects of the multidrug transporter P-glycoprotein on cellular responses to ionizing radiation. Cancer Res. 60, 2576-2578 (2000).
42. K. Nakatani, H. Sakaue, D. A. Thompson, R. J. Weigel and R. A. Roth, Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site. Biochem. Biophys. Res. Commun. 257, 906-910 (1999).
43. S. Masure, B. Haefner, J. J. Wesselink, E. Hoefnagel, E. Mortier, P. Verhasselt, A. Tuytelaars, R. Gordon and A. Richardson, Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3. Eur. J. Biochem. 265, 353-360 (1999).
44. D. P. Brazil, Z. Z. Yang and B. A. Hemmings, Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem. Sci. 29, 233-242 (2004).
45. T. F. Franke, C. P. Hornik, L. Segev, G. A. Shostak and C. Sugimoto, PI3/Akt and apoptosis: size matters. Oncogene 22, 8983-8998 (2003).
46. J. Schafer, J. Bachtler, A. Engling, J. B. Little, K. J. Weber and F. Wenz, Suppression of apoptosis and clonogenic survival in irradiated human lymphoblasts with different TP53 status. Radiat. Res. 158, 699-706 (2002).
47. K. M. Boatright, M. Renatus, F. L. Scott, S. Sperandio, H. Shin, I. M. Pedersen, J. E. Ricci, W. A. Edris, D. P. Sutherlin and G. S. Salvesen, A unified model for apical caspase activation. Mol. Cell 11, 529-541 (2003).
48. D. W. Nicholson, Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6, 1028-1042 (1999).
49. Z. L. Chu, F. Pio, Z. Xie, K. Welsh, M. Krajewska, S. Krajewski, A. Godzik and J. C. Reed, A novel enhancer of the Apaf1 apoptosome involved in cytochrome c-dependent caspase activation and apoptosis. J. Biol. Chem. 276, 9239-9245 (2001).
50. L. Agostini, F. Martinon, K. Burns, M. F. McDermott, P. N. Hawkins and J. Tschopp, NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20, 319-325 (2004).
51. J. M. Bruey, N. Bruey-Sedano, R. Newman, S. Chandler, C. Stehlik and J. C. Reed, PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-κB and caspase-1 activation in macrophages. J. Biol. Chem. 279, 51897-51907 (2004).
52. J. A. Gracie, S. E. Robertson and I. B. Mclnnes, Interleukin-18. J. Leukoc. Biol. 73, 213-224 (2003).
53. P. Li, H. Allen, S. Banerjee, S. Franklin, L. Herzog, C. Johnston, J. McDowell, M. Paskind, L. Rodman and J. Salfeld, Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 80, 401-411 (1995).
54. S. Gupta, V. Radha, C. Sudhakar and G. Swarup, A nuclear protein tyrosine phosphatase activates p53 and induces caspase-1-dependent apoptosis. FEBS Lett. 532, 61-66 (2002).
55. A. R. King, S. E. Francis, C. J. Bridgeman, H. Bird, M. K. Whyte and D. C. Crossman, A role for caspase-1 in serum withdrawal-induced apoptosis of endothelial cells. Lab. Invest. 83, 1497-1508 (2003).
56. S. Sadasivam, S. Gupta, V. Radha, K. Batta, T. K. Kundu and G. Swarup, Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis. Oncogene 24, 627-636 (2005).
57. J. Hitomi, T. Katayama, Y. Eguchi, T. Kudo, M. Taniguchi, Y. Koyama, T. Manabe, S. Yamagishi, Y. Bando and M. Tohyama, Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death. J. Cell Biol. 165, 347-356 (2004).